Intraperitoneal chemotherapy: Hot, timely, and relevant?
Menée auprès de 149 patientes atteintes d'un cancer épithélial de l'ovaire de stade avancé, cette étude évalue la faisabilité d'une chimiothérapie intrapéritonéale après une chirurgie de réduction tumorale
The use of hyperthermic intraperitoneal chemotherapy has been growing in popularity in recent years. Even with a positive randomized trial, issues concerning the study design and the statistical analysis raise questions about whether this technique should be recommended as a standard-of-care approach. There are many questions that remain unanswered.
Cancer , éditorial, 2020